ORIGINAL PAPER
Evaluation of serum homocysteine level and its relation with carotid intima-media thickness in patients of chronic kidney disease
1
Department of Medicine, Pt B D Sharma University of Health Sciences, Rohtak, India
Submission date: 2016-12-11
Final revision date: 2017-06-10
Acceptance date: 2017-09-15
Publication date: 2017-12-31
Medical Studies 2017;33(4):247-253
KEYWORDS
TOPICS
ABSTRACT
Introduction: Patients with chronic kidney disease (CKD) are at high risk for the development of cardiovascular disease (CVD). The intima-media thickness (IMT) is the best-studied sonographic marker for early atherosclerotic vascular wall lesions. Homocysteine is an important non-traditional risk factor for CVD in CKD patients.
Aim of the research: To explore the relationship between elevated serum homocysteine level and its relationship with carotid intima-media thickness in patients with CKD.
Material and methods: The study was undertaken in 60 adult patients with chronic renal failure. The patients were divided into three groups: group I had subjects with CKD (stage 3); group II had subjects with CKD (stage 4) on conservative therapy; and group III had subjects with CKD (stage 5) on regular haemodialysis at least 3–4 times per week. Carotid sonography was done in all patients at the time of inclusion in the study. The patients in all the groups were then followed for 3 months and the relevant investigations were carried out, initially at the time of presentation, and then at 3 months in group III patients. The patients were monitored for various renal parameters along with serum homocysteine.
Results: The value of carotid intima-media thickness (CA-IMT) was increased in groups II and III as compared to group I. Patients in group III had higher levels of serum homocysteine as compared to patients in groups I and group II. The comparison of homocysteine levels between three groups was also highly statistically significant. No correlation was observed between serum homocysteine levels and carotid artery IMT in all the three groups.
Conclusions: The present observations show that baseline serum homocysteine levels and carotid artery IMT levels were elevated at baseline in all the three groups, with progressive increase in their values with decline in renal function.
Aim of the research: To explore the relationship between elevated serum homocysteine level and its relationship with carotid intima-media thickness in patients with CKD.
Material and methods: The study was undertaken in 60 adult patients with chronic renal failure. The patients were divided into three groups: group I had subjects with CKD (stage 3); group II had subjects with CKD (stage 4) on conservative therapy; and group III had subjects with CKD (stage 5) on regular haemodialysis at least 3–4 times per week. Carotid sonography was done in all patients at the time of inclusion in the study. The patients in all the groups were then followed for 3 months and the relevant investigations were carried out, initially at the time of presentation, and then at 3 months in group III patients. The patients were monitored for various renal parameters along with serum homocysteine.
Results: The value of carotid intima-media thickness (CA-IMT) was increased in groups II and III as compared to group I. Patients in group III had higher levels of serum homocysteine as compared to patients in groups I and group II. The comparison of homocysteine levels between three groups was also highly statistically significant. No correlation was observed between serum homocysteine levels and carotid artery IMT in all the three groups.
Conclusions: The present observations show that baseline serum homocysteine levels and carotid artery IMT levels were elevated at baseline in all the three groups, with progressive increase in their values with decline in renal function.
REFERENCES (29)
1.
Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081.
2.
Van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey AS, de Jong P, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium, van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey AS, de Jong PE, Gansevoort RT, Levey A, El-Nahas M, Eckardt KU, Kasiske BL, Ninomiya T, Chalmers J, Macmahon S, Tonelli M, Hemmelgarn B, Sacks F, Curhan G, Collins AJ, Li S, Chen SC, Hawaii Cohort KP, Lee BJ, Ishani A,Neaton J, Svendsen K, Mann JF, Yusuf S, Teo KK, Gao P, Nelson RG, Knowler WC, Bilo HJ, Joosten H, Kleefstra N, Groenier KH, Auguste P, Veldhuis K, Wang Y, Camarata L, Thomas B, Manley T. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int 2011; 79: 1341-1352.
3.
Rostand SG, Gretes JC, Kirk KA, Rutsky EA, Andreoli TE. Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 1979; 16: 600-611.
4.
Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from Hypertension Detection and Follow-Up Program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989; 13 (Suppl 1): 180-193.
5.
Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kid Dis 2000; 35 (Suppl 1): 117-131.
6.
Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffness and vascular calcification in end stage renal disease. Nephrol Dial Transplant 2000; 15: 1014-1021.
7.
Cobble M, Bale B. Carotid intima-media thickness: knowledge and application to everyday practice. Postgrad Med 2010; 122: 10-18.
9.
National Kidney Foundation. KDOQI kidney disease outcome quality initiative. Am J Kidney Dis 2002; 39 (Suppl 1): S1-S266.
10.
Jungers P, Massy ZA, Nguyen Khoa T, Fumeron C, Labrunie M, Lacour B, Descamps-Latscha B, Man NK. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 1997; 12: 2597-2602.
11.
Foley RN. Clinical epidemiology of cardiac disease in dialysis patients. Left ventricular hypertrophy, ischemic heart disease and cardiac failure. Semin Dial 2003; 16: 111-117.
12.
Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Int Med 2004; 164: 659-663.
13.
Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998; 339: 799-805.
14.
Xu J, Li G, Wang P, Velazquez H, Yao X, Li Y, Wu Y, Peixoto A, Crowley S, Desir GV. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest 2005; 115: 1275-1280.
15.
Kharlamova UV, Ilicheva OE. Effect of homocysteine on left ventricular structural and functional parameters in patients on programmed hemodialysis. TerArkh 2013; 85: 90-93.
16.
Marti F, Vollenweider P, Marques-Vidal PM, Mooser V, Waeber G, Paccaud F, Bochud M. Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study. BMC Public Health 2011; 11: 733.
17.
Guldener CV, Stam F, Stehouwer CD. Homocysteine metabolism in renal failure. Kidney Int 2001; 59 (Suppl 78): S234-S237.
18.
Moustapha A, Naso A, Nahlawi M, Gupta A, Arheart KL, Jacobsen DW, Robinson K, Dennis VW. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 1998; 97: 138-141.
19.
Mallamaci F, Zoccali C, Tripepi G, Fermo I, Benedetto FA, Cataliotti A, Bellanuova I, Malatino LS, Soldarini A. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 2002; 61: 609-614.
20.
Arnadottir M, Berg AL, Hegbrant J, Hultberg B. Influence of haemodialysis on plasma total homocysteine concentration. Neprol Dial Transplant 1999; 14: 142-146.
21.
Hewitson CL, Whiting MJ, Barbara JA, Mangoni AA. Acute effects of haemodialysis on biochemical modulators of endothelial function. J Intern Med 2007; 262: 571-580.
22.
Helfand M, Buckley DI, Freeman M, Fu R, Rogers K, Fleming C, Humphrey LL. Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151: 496-507.
23.
European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J. Hypertens 2003; 21: 1011-1053.
24.
Kennedy R, Case C, Fathi R, Johnson D, Isbel N, Marwick TH. Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease. Am J Med 2001; 110: 198-204.
25.
Sunil Kumar K, Lakshmi AY, Srinivas Rao PV, Das GC, Siva Kumar V. Carotid intima media thickness in patients with end-stage renal disease. Indian J Nephrol 2009; 19: 13-14.
26.
Paul J, Dasgupta S, Ghosh MK. Carotid artery intima media thickness as a surrogate marker of atherosclerosis in patient with chronic renal failure on hemodialysis. N Am J Med Sci 2012; 4: 77-80.
27.
Aggarwal HK, Jain D, Lathar M, Yadav RK, Sawhney A. Lipoprotein-A and carotid intima media thickness as cardiovascular risk factors in patients of chronic kidney disease. Ren Fail 2010; 32: 647-652.
28.
Duran M, Unal A, Inanc MT, Kaya MG, Kalay N, Ocak A, Uysal OK, Oguzhan A. Changes in carotid intima-media thickness over two years in patients on haemodialysis. J Pak Med Assoc 2012; 62: 575-579.
29.
Leskinen Y, Lehtimäki T, Loimaala A, Lautamatti V, Kallio T, Huhtala H, Salenius JP, Saha H. Carotid atherosclerosis in chronic renal failure – the central role of increased plaque burden. Atherosclerosis 2003; 171: 295-302.
Share
RELATED ARTICLE
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
